NuGen Medical Devices IncOTCQB:NGMDFView on Canadian Exchange
- LAST PRICE0.0697
- TODAY'S CHANGE (%)-0.0020 (-2.7894%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0697 / 0.0717
- Day Range
- 52 Week Range
- Volume10,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NGMDF |
|---|
May 30, 2024
NuGen Announces Release of Financial Results for Q1 2024 & Updates on Strong Commercial Momentum in Q2, from 5:16PM ET on Thursday May 30, 2024 by Dow Jones
5:16PM ET on Thursday May 30, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
NuGen Medical Devices Inc | 21.6M | 0.0x | --- |
Company Information
NuGen Medical Devices Inc. is a Canada-based specialty medical device company. The Company is engaged in marketing and selling its InsuJet needle-free injection system designed to improve the lives of millions of diabetics. Its principal business is the research, development and commercialization of needle-free injection devices and systems for the administration of subcutaneous medication. It is developing products using its needle-free delivery technology in several fields including, but not limited to, diabetes, semaglutide, growth and fertility hormone, as well as deoxyribonucleic acid (DNA) and conventional/pediatric vaccines. It is focusing its development efforts on needle free devices in the area of liquid jet delivery through the InsuJet platform. The Company's InsuJet technology platform is based on jet-stream administration of liquid drugs. The Company manufactures and commercializes needle-free injection systems and sells in over 40 countries globally.
Contact Information
- Headquarters
- 18 King Street East, Suite 1400Toronto, ON, Canada M5C 1C4
- Phone
- 647-501-3290
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $21.6M |
|---|---|
Revenue (TTM) | $331.4K |
Shares Outstanding | 216.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.06 |
Book Value | $-0.01 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 65.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,431.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
